At-rich sequence binding protein 1: Contribution to tumor progression and metastasis of human ovarian carcinoma

Oncology Letters

Volumn 3, Issue 4, 2012, Pages 865-870

  Xiang, Jiangdong ^a   Zhou, Lina ^b   Li, Shuangdi ^a   Xi, Xiaowei ^a   Zhang, Jiarong ^a   Wang, Yanqiu ^a   Yang, Yixia ^a   Liu, Xuelian ^a   Wan, Xiaoping ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Shanghai Municipal Key Clinical Specialty   (China)

Author keywords

Metastasis; Ovarian cancer; Prognosis; Progression; SATB1

Indexed keywords

GELATINASE B; MESSENGER RNA; NUCLEAR PROTEIN; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ARTICLE; BORDERLINE CYSTADENOMA; CANCER GROWTH; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYSTADENOMA; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; OVARY CARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING;

EID: 84863164737     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.571     Document Type: Article

References (26)

1. Partridge E, Kreimer AR, Greenlee RT, et al: Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol 113: 775-782, 2009.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
3. Tingulstad S, Skjeldestad FE, Halvorsen TB and Hagen B: Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol 101: 885-891, 2003.
4. Balbi G, Manganaro MA, Monteverde A, Landino I, Franzese C and Gioia F: Ovarian cancer: lymph node metastases. Eur J Gynaecol Oncol 30: 289-291, 2009.
5. Brewer MA, Johnson K, Follen M, Gershenson D and Bast R: Prevention of ovarian cancer: intraepithelial neoplasia. Clin Cancer Res 9: 20-30, 2003.
6. Concin N, Hefler L, Van Bavel J, et al: Biological markers in pT1 and pT2 ovarian cancer with lymph node metastases. Gynecol Oncol 89: 9-15, 2003.
7. Jemal A, Tiwari RC, Murray T, et al: Cancer statistics, 2004. CA Cancer J Clin 54: 9-29, 2004.
8. Takeshima N, Hirai Y, Umayahara K, Fujiwara K, Takizawa K and Hasumi K: Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors. Gynecol Oncol 99: 427-431, 2005.
9. Ayhan A, Gultekin M, Taskiran C, Celik NY, Usubutun A, Kucukali T and Yuce K: Lymphatic metastasis in epithelial ovarian carcinoma with respect to clinicopathological variables. Gynecol Oncol 97: 400-404, 2005.
10. Han HJ, Russo J, Kohwi Y and Kohwi-Shigematsu T: SATB1 reprogrammes gene expression to promote breast tumor growth and metastasis. Nature 452: 187-193, 2008.
11. Lu X, Cheng C, Zhu S, et al: SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncol Rep 24: 981-987, 2010.
12. Rygiel AM, Davelaar AL, Milano F, Fockens P and Krishnadath KK: SATB1 influences expression of cytokines in colorectal cell lines and is associated with a more aggressive phenotype. AGA abs. S2050, 2009.
13. Agrelo R, Souabni A, Novatchkova M, et al: SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells. Dev Cell 16: 507-516, 2009.
14. Zhao XD, Ji WY, Zhang W, He LX, Yang J, Liang HJ and Wang LL: Overexpression of SATB1 in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 72: 1-5, 2010.
15. Gotzmann J, Meissner M and Gerner C: The fate of the nuclear matrix-associated-region-binding protein SATB1 during apoptosis. Cell Death Differ 7: 425-438, 2000.
16. Gong F, Sun L, Wang Z, et al: The BCL2 gene is regulated by a special AT-rich sequence binding protein 1-mediated long range chromosomal interaction between the promoter and the distal element located within the 3'-UTR. Nucleic Acids Res 39: 4640-4652, 2011.
17. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25: 402-408, 2001.
18. Harlan LC, Clegg LX and Trimble EL: Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol 21: 3488-3494, 2003.
19. Yoshida BA, Sokoloff MM, Welch DR and Rinker-Schaeffer CW: Metastasis-suppressor genes: a riview and perspective on an emerging field. J Natl Cancer Inst 92: 1717-1730, 2000.
20. Cheung ST, Chen X, Guan XY, et al: Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor. Cancer Res 62: 4711-4721, 2002.
21. Cai S, Han HJ and Kohwi-Shigematsu T: Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat Genet 34: 42-51, 2003.
22. Cai S, Lee CC and Kohwi-Shigematsu T: SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat Genet 38: 1278-1288, 2006.
23. Yamaguchi H, Tateno M and Yamasaki K: Solution structure and DNA-binding mode of the matrix attachment region-binding domain of the transcription factor SATB1 that regulates the T-cell maturation. J Biol Chem 281: 5319-5327, 2006.
24. Ellis LM: Epidermal growth factor receptor in tumor angiogenesis. Hematol Oncol Clin North Am 18: 1007-1021, 2004.
25. Hung WC, Tseng WL, Shiea J and Chang HC: Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells. Cancer Lett 288: 156-161, 2010.
26. Hao L, Zhang C, Qiu Y, et al: Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer. Cancer Lett 253: 34-42, 2007.